Non-revascularisation of acute coronary syndrome with ST elevation;Non-reperfusion au cours des syndromes coronaires aigus avec sus-décalage du segment ST

Archives des Maladies du Coeur et des Vaisseaux

Volumn 97, Issue 3, 2004, Pages 195-200

  Zeller, M ^a   Dentan, G ^b   Hadj Hamou, K ^c   Beer, J C ^a   L'Huillier, I ^a   Janin Manificat, L ^c   Makki, H ^c   Laurent, Y ^c   Louis, P ^a   Cottin, Y ^a   Wolf, J E ^a  

^a HÔPITAL DU BOCAGE   (France)

^b Clinique de Fontaine   (France)

^c CENTRE HOSPITALIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CLINICAL STUDY; ELDERLY CARE; FEMALE; FIBRINOLYTIC THERAPY; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE ISCHEMIA; HEART MUSCLE NON REVASCULARIZATION; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATION; RICO STUDY; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE DISEASE; AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BUNDLE-BRANCH BLOCK; COMORBIDITY; CORONARY DISEASE; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; FRANCE; HOSPITALIZATION; HUMANS; MALE; MYOCARDIAL REVASCULARIZATION; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOLYTIC THERAPY;

EID: 12144286401     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Danchin N. Strategies thérapeutiques au stade aigu de l'infarctus du myocarde. Arch Mol Cœur 1998; 91: 7-8.
2. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996; 348: 771-5.
3. Loubeyre C, Lefevre T, Louvard Y et al. Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent. Eur Heart J 2001; 22: 1067-9.
4. Bonnefoy E, Lapostolle F, Leizorovicz A et al. Comparaison of angioplasty and prehospital thrombolysis in acute myocardial infarction study group. Lancet 2002; 360: 814-6.
5. French WJ. Trends in acute myocardial infarction management: use of the National Registry of Myocardial Infarction in quality improvement. Am J Cardiol 2000; 85 (5A): 5B-12B.
6. Rogers WJ, Bowlby U, Chandra NC et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation 1994; 90: 2103-14.
7. Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, Lopez-Sendon J. GRACE Investigators. Practice variation and missed opportunities far reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002; 359: 373-7.
8. Morrow DA, Antamnn M, Charlesworth A et al. TIMI risk score for ST-elevatian Myocardial Infarction: a convenient, bedside, clinical score for risk assessment at presentation. Circulation 2000; 102: 2031-7.
9. Zeller M, Ravisy J, L'Huillier I et al. Applicotion des scares de stratification du risque dans l'infarctus du myocarde en phase aiguë. Données de RICO (ObseRvatoire des Infarctus de Côte-d'Or). Arch Mol Cœur 2003; 96: 841-7.
10. Ryan TJ, Antman EM, Brooks NH et al. 1999 update: ACC/AHA Guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999; 100: 1016-30.
11. Van de Werf F, Ardissino D, Betriu A et al. Task force on the management of acute myocardial infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2003; 24: 28-66.
12. Danchin N, Vaur L, Genes N et al. Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the «real world»: one-year results from a nationwide French survey. Circulation 1999; 99: 2639-44.
13. Rogers WJ, Canto JG, Lambrew CT et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 2000; 36: 2056-63.
14. Heer T, Schiele R, Schneider S et al. Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry). Am J Cardiol 2002; 89: 511-7.
15. Juliard JM, Himbert D, Golmard JL et al. Can we provide reperfusion therapy to all unselected patients admitted with acute myocardial infarction? J Am Coll Cardiol 1997; 30: 157-64.
16. Mehta RH, Rathore SS, Radford MJ, Wang Y, Wang Y, Krumholz HM. Acute myocardial infarction in the elderly: differences by age. J Am Coll Cardiol 2001; 38: 736-41.
17. Danchin N, Angioi M, Demicheli T et al. USIK Registry Participants. Effect a reperfusion therapy on long-term outcome in patients > 70 years of age. Am J Cardiol 2002; 90: 1142-5.
18. Krumholz HM, Murillo JE, Chen J et al. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. JAMA 1997; 277: 1683-8.
19. Rathore SS, Mehta RH, Wang Y, Radford MJ, Krumholz HM. Effects of age on the quality of care provided to older patients with acute myocardial infarction. Am J Med 2003; 114: 307-15.
20. Antoniucci D, Valenti R, Migliorini A et al. Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol 2002; 89: 1248-52.
21. Califf RM, Pieper KS, Lee KL et al., for the GUSTO I investigators. Prediction of 1-Year survival after thrombolysis for acute myocardial infarction in the global utilization of treptokinase and TPA for occluded coronary arteries trial. Circulation 2000; 101: 2231-8.
22. Antmann EM, Cohen M, Berninck PJ et al. The TIMI risk score for unstable angina/non-St Elevation MI. A method for prognostication and therapeutic decision making. JAMA 2000; 284: 835-42.
23. Boersma E, Pieper KS, Sqteyberg EW et al. for the PURSUIT investigators. Predictors of outcome in patients with acute coronary syndromes without persistent ST-elevation. Results from an international trial of 9461 patients. Circulation 2000; 101: 2557-67.
24. Singh M, Reeder GS, Jacobsen SJ, Weston S, Killian J, Roger V.L. Scores for post-myocardial infarction risk stratification in the community. Circulation 2002; 106: 2309-14.
25. Gumina RJ, Wright RS, Kopecky SL et al. Strong predictive value of TIMI risk score analysis for in-hospital and long-term survival of patients with right ventricular infarction. Eur Heart J 2002; 23: 1678-83.
26. Samaha FF, Kimmel SE, Kizer JR, Goyal A, Wade M, Boden WE. Usefulness of the TIMI risk score in predicting both short- and long-term outcomes in the Veterans Affairs Non-Q-Wave Myocardial Infarction Strategies In-Hospital (VANQWISH) Trial. Am J Cardiol 2002; 90: 922-6.
27. Zijlstra F. Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction. Eur Heart J 2000; 21: 1487-9.
28. McCullough PA, O'Neill WW, Graham M et al. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial. J Am Coll Cardiol 1998; 32: 596-605.